# Quince Therapeutics, Inc. (QNCX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/QNCX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -39.58M | $ -26.51M | $ 0 | $ 108.49M |
| 2025 | $ 0 | $ -85.99M | $ -42.78M | $ 18.47M | $ -35.71M |
| 2024 | $ 0 | $ -59.73M | $ -33.80M | $ 14.81M | $ 30.15M |
| 2023 | $ 0 | $ -33.94M | $ -19.95M | $ 13.81M | $ 85.08M |
| 2022 | $ 0 | $ -57.71M | $ -49.34M | $ 453.0K | $ 100.59M |
| 2021 | $ 0 | $ -106.91M | $ -75.02M | $ 1.16M | $ 118.59M |
| 2020 | $ 0 | $ -97.90M | $ -64.80M | $ 446.0K | $ 172.26M |
| 2019 | $ 0 | $ -47.73M | $ -43.02M | $ 0 | $ 115.48M |
| 2018 | $ 0 | $ -16.48M | $ -15.73M | $ 0 | $ 71.42M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.14 |
| Current Ratio | 14.52 |

## Other views

- [Metrics](https://sponda.capital/en/QNCX.md)
- [Charts](https://sponda.capital/en/QNCX/charts.md)
- [Compare](https://sponda.capital/en/QNCX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.